Torrent Pharmaceuticals Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Torrent Pharmaceuticals Limited
Symbol
TORNTPHARM
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Not Applicable
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
27-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Notes On Website In Terms Of Listing Regulations Explanatory Text Block
criteria for making payment to NEDs was disclosed in AR 2024-25 and the same will be disclosed in AR 2025-26.
Disclosure Of Notes To Annexure1Explanatory Text Block
The report submitted in the previous quarter was placed before Board of Directors in its meeting held on 13-Feb-26 There were no comments/observations/advice of Board of Directors on the report. This report shall be placed at the ensuing Board Meeting.
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.torrentpharma.com/index.php/investors/annual_return
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://www.torrentpharma.com/investors/financial-info/quarterly-results/
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.torrentpharma.com/investors/financial-info/quarterly-results/
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://www.torrentpharma.com/assets/Dividend_Policy.pdf
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.torrentpharma.com/assets/Policy_on_Material_Disclosures_aa771c1f9f.pdf
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://www.torrentpharma.com/investors/financial-info/subsidiary-reports/
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://torrentpharma.com/index.php/investors/credit_ratings
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.torrentpharma.com/business-area/overview/
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://www.torrentpharma.com/assets/WBP_b639fe8a9a.pdf
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.torrentpharma.com/investors/financial-info/quarterly-results/
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://www.torrentpharma.com/assets/Policy_for_determination_of_Material_Subsidiaries.pdf
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://www.torrentpharma.com/docs/RPT_policy_2026_70b1353a45.pdf
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.torrentpharma.com/investors/corp-governance/intimation/
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://torrentpharma.com/index.php/investors/disclosures
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://torrentpharma.com/index.php/investors/disclosures
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://torrentpharma.com/pdf/investors/Disclosure-of-events-or-information.pdf
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.torrentpharma.com/investors/overview/
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://www.torrentpharma.com/investors/corp-governance/moa-aoa/
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
https://www.torrentpharma.com/investors/financial-info/quarterly-results/
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://www.torrentpharma.com/assets/AC_Rto_S_Es2025_22a86e6db7.pdf
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Not Applicable
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE685A01028
Market Capitalisation As Per Immediate Previous Financial Year
Top 100 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
CHINTAN M. TRIVEDI
Name Of Signatory Affirmations
CHINTAN M. TRIVEDI
Name Of Signatory For Annual Affirmations
CHINTAN M. TRIVEDI
Name Of Signatory For Quartely Affirmations
Chintan M Trivedi
Name Of The Company
Torrent Pharmaceuticals Limited
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Ahmedabad
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
Not Applicable during this quarter
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
T00128
Scrip Code
500420
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
TORNTPHARM
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Not Applicable
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

Disclosure Of Notes On Composition Of Board Of Directors Explanatory Text Block
1. The Chairperson is in Executive Position and categorized as Managing Director. 2. The Chairperson is also related to Managing Director 3. Ms. Nayantara Bali have been appointed for the period of three years w.e.f 07-Mar-2019. Reappointed for the period of 5 years w.e.f. 07-Mar-2022. 4. Ms. Ameera Shah was appointed for the period of 3 years w.e.f. 02-Aug-2018. Reappointed for the period of 5 years w.e.f. 02-Aug-21. 5. Manish Choksi appointed for period of 5 years. 6. Nikhil Khattau appointed for period of 5 years. 7. SEBI vide its circular dated 31st December, 2024 provided the format for Integrated Filing (Governance) which provides disclosure of Chairmanship in Audit Committee & Stakeholders committee held in "listed entities" only. However, guidance note issued by NSE in this respect provides to submit information related to Chairmanship in Audit Committee & Stakeholders Committee of all "public companies whether listed or unlisted". Hence, we have considered the guidance note provided by NSE while preparing CGR and have provided Chairmanship of Audit and Stakeholder Committee for all the public companies, whether listed or not. 8. Aman Mehta appointed as Managing Director, for a period of 5 years effective from 01-Aug-25 with the pre-closure of his existing term as Wholetime Director.
The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
Yes
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedSpecial ResolutionInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrSamir Uttamlal Mehta******00061903Executive DirectorChairpersonCEO-MD18-Sep-1963NoNot Applicable20-Aug-198601-Apr-20252020
2MsAmeera Sushil Shah******00208095Non-Executive - Independent DirectorNot Applicable24-Sep-1979NoNot Applicable02-Aug-201802-Aug-2021922131
3MsNayantara Bali******03570657Non-Executive - Independent DirectorNot Applicable13-Jun-1966NoNot Applicable07-Mar-201907-Mar-2022852220
4MrManish Mahendra Choksi******00026496Non-Executive - Independent DirectorNot Applicable12-Sep-1967NoNot Applicable29-Jul-2022444350
5MrAman Mehta******08174906Executive DirectorNot ApplicableMD28-Aug-1991NoNot Applicable01-Aug-202201-Aug-20252010
6MrNikhil Nirvan Khattau******00017880Non-Executive - Independent DirectorNot Applicable20-Mar-1963NoNot Applicable01-Oct-2023303141
7MrJinal Sudhirbhai Mehta******02685284Non-Executive - Non Independent DirectorNot Applicable11-Mar-1983NoNot Applicable24-May-20242000

Committee Disclosures

Entry CompComit122
Date of Appointment
06-Apr-2019
Entry CompComit123
Date of Appointment
29-Jul-2022
Entry CompComit124
Date of Appointment
06-May-2025
Entry CompComit14
Date of Appointment
14-Oct-2023
Entry CompComit15
Date of Appointment
02-Aug-2018
Entry CompComit16
Date of Appointment
06-Apr-2019
Entry CompComit17
Date of Appointment
16-Mar-2026
Entry CompComit41
Date of Appointment
14-Oct-2023
Entry CompComit42
Date of Appointment
08-Feb-2021
Entry CompComit43
Date of Appointment
14-Oct-2023
Entry CompComit68
Date of Appointment
02-Aug-2018
Entry CompComit69
Date of Appointment
24-May-2023
Entry CompComit70
Date of Appointment
14-Oct-2023
Entry CompComit95
Date of Appointment
14-Oct-2023
Entry CompComit96
Date of Appointment
11-May-2022
Entry CompComit97
Date of Appointment
20-May-2019
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.torrentpharma.com/docs/Composition_Of_Various_Committees_Of_Board_Of_Directors_16_03_2026_5050830cc2.pdf
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
00017880
Member Name
Nikhil Nirvan Khattau
Notes
Mr. Nikhil Khattau has been appointed as Chairperson of the Committee wef from 24-May-24.
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
00208095
Member Name
Ameera Sushil Shah
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
03570657
Member Name
Nayantara Bali
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
00026496
Member Name
Manish Mahendra Choksi
Notes
Mr. Manish Choksi has been appointed as Member of Audit Committee wef 16-Mar-26.
Position
Non-Executive - Independent Director

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
03570657
Member Name
Nayantara Bali
Notes
Ms. Nayantara Bali has been appointed as Chairperson of the Committee wef 21-Oct-22
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00026496
Member Name
Manish Mahendra Choksi
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00017880
Member Name
Nikhil Nirvan Khattau
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
00026496
Member Name
Manish Mahendra Choksi
Notes
Mr. Manish Choksi has been appointed as Chairperson of the Committee wef 24-May-24
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
03570657
Member Name
Nayantara Bali
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00208095
Member Name
Ameera Sushil Shah
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Chairperson
Director DIN
00017880
Member Name
Nikhil Nirvan Khattau
Notes
Mr. Nikhil Khattau has been appointed as Chairperson of the Committee wef from 02-Apr-24.
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
03570657
Member Name
Nayantara Bali
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
99999999
Member Name
Sudhir Menon
Notes
DIN is not mentioned as he is CFO and not a director
Position
Chief Financial Officer

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
00208095
Member Name
Ameera Sushil Shah
Notes
Ms. Ameera Shah has been appointed as Chairperson of the Committee wef from 24-May-24.
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
08174906
Member Name
Aman Mehta
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00017880
Member Name
Nikhil Nirvan Khattau
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
07-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
13-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
97
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
07-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
13-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
97
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
05-Jan-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Previous Quarter
07-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Previous Quarter
05-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
27
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
1
Total Number Of Directors As On Date Of The Meeting
2
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://torrentpharma.com/index.php/investors/shareHolder
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://torrentpharma.com/index.php/investors/shareHolder
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
15
No Of Investor Complaints During The Period
-1
No Of Investor Complaints Received During The Period
14
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
1
Entry PY_I
No Of Investor Complaints
2
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Not Applicable
Reason For Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Not Applicable To The Entity
Not Applicable during this quarter
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
No
Reason For Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Not Applicable To The Entity
Not Applicable during this quarter
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
No
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
Not Applicable during this quarter
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No